retatrutide clinical trials weight loss trial Retatrutide is getting a lot of attention, and for good reason ESC 2024: Retatrutide improves lipid

Renal impairment GLP-1 RAs are generally safe in patients with CKD and have demonstrated nephroprotective effects in the FLOW trial, where semaglutide significantly reduced the composite renal endpoint (hospitalization for acute kidney injury, sustained 50% decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, or renal death) in patients with type 2 diabetes and CKD [15]

Even modest weight reductions of 5-10% can restore normal menstrual function in some women with insulin resistance or PCOS, according to reproductive endocrinology research

People who take advantage of this period to build sustainable habits are better equipped to manage their weight after the medication is discontinued

Risk factors for hypothalamic obesity in patients with adult-onset craniopharyngioma: a consecutive series of 120 cases

pharmacies Injection supplies (syringes, needles) for injectable formats Ongoing medical support through licensed providers How It Works Complete a health intake quiz online (about 2-5 minutes) A licensed medical provider reviews your information and determines eligibility If approved, you may receive a prescription directly or be scheduled for a video consultation at no extra cost Your prescription goes to a licensed compounding pharmacy and ships overnight Ongoing refills require monthly eligibility confirmation